370 related articles for article (PubMed ID: 10747881)
1. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.
Souza JM; Giasson BI; Chen Q; Lee VM; Ischiropoulos H
J Biol Chem; 2000 Jun; 275(24):18344-9. PubMed ID: 10747881
[TBL] [Abstract][Full Text] [Related]
2. Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications.
Norris EH; Giasson BI; Ischiropoulos H; Lee VM
J Biol Chem; 2003 Jul; 278(29):27230-40. PubMed ID: 12857790
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine 125 of alpha-synuclein plays a critical role for dimerization following nitrative stress.
Takahashi T; Yamashita H; Nakamura T; Nagano Y; Nakamura S
Brain Res; 2002 May; 938(1-2):73-80. PubMed ID: 12031537
[TBL] [Abstract][Full Text] [Related]
4. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
[TBL] [Abstract][Full Text] [Related]
5. Oxidative modifications of alpha-synuclein.
Ischiropoulos H
Ann N Y Acad Sci; 2003 Jun; 991():93-100. PubMed ID: 12846977
[TBL] [Abstract][Full Text] [Related]
6. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.
Duda JE; Giasson BI; Chen Q; Gur TL; Hurtig HI; Stern MB; Gollomp SM; Ischiropoulos H; Lee VM; Trojanowski JQ
Am J Pathol; 2000 Nov; 157(5):1439-45. PubMed ID: 11073803
[TBL] [Abstract][Full Text] [Related]
7. Induction of alpha-synuclein aggregation by intracellular nitrative insult.
Paxinou E; Chen Q; Weisse M; Giasson BI; Norris EH; Rueter SM; Trojanowski JQ; Lee VM; Ischiropoulos H
J Neurosci; 2001 Oct; 21(20):8053-61. PubMed ID: 11588178
[TBL] [Abstract][Full Text] [Related]
8. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
Norris EH; Giasson BI
Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
[TBL] [Abstract][Full Text] [Related]
9. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity.
Zhou W; Freed CR
J Biol Chem; 2004 Mar; 279(11):10128-35. PubMed ID: 14699135
[TBL] [Abstract][Full Text] [Related]
11. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
12. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH
J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652
[TBL] [Abstract][Full Text] [Related]
13. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
[TBL] [Abstract][Full Text] [Related]
15. Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.
Uversky VN; Fink AL
FEBS Lett; 2002 Jul; 522(1-3):9-13. PubMed ID: 12095610
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease and other alpha-synucleinopathies.
Goedert M
Clin Chem Lab Med; 2001 Apr; 39(4):308-12. PubMed ID: 11388653
[TBL] [Abstract][Full Text] [Related]
17. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
[TBL] [Abstract][Full Text] [Related]
18. [Alpha-synucleinopathies].
Ferrer I
Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
[TBL] [Abstract][Full Text] [Related]
19. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
20. The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease.
Al-Hilaly YK; Biasetti L; Blakeman BJ; Pollack SJ; Zibaee S; Abdul-Sada A; Thorpe JR; Xue WF; Serpell LC
Sci Rep; 2016 Dec; 6():39171. PubMed ID: 27982082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
